These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 31997044)

  • 1. Small Molecules with Big Impacts on Cardiovascular Diseases.
    Mirzadeh Azad F; Arabian M; Maleki M; Malakootian M
    Biochem Genet; 2020 Jun; 58(3):359-383. PubMed ID: 31997044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as Candidate Drug Targets for Cardiovascular Diseases.
    Hang P; Guo J; Sun C; Du Z
    Curr Drug Targets; 2017; 18(4):463-472. PubMed ID: 26926467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs: roles in cardiovascular development and disease.
    Kalayinia S; Arjmand F; Maleki M; Malakootian M; Singh CP
    Cardiovasc Pathol; 2021; 50():107296. PubMed ID: 33022373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Significance of MicroRNAs, Long Non-Coding RNAs, and CircRNAs in Cardiovascular Diseases.
    Singh DD; Kim Y; Choi SA; Han I; Yadav DK
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA and Cardiovascular Diseases.
    Çakmak HA; Demir M
    Balkan Med J; 2020 Feb; 37(2):60-71. PubMed ID: 32018347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miRNAs as biomarkers in cardiovascular diseases.
    Kaneto CM; Nascimento JS; Prado MSJG; Mendonça LSO
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2234-2243. PubMed ID: 30915771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases.
    Sayed AS; Xia K; Salma U; Yang T; Peng J
    Heart Lung Circ; 2014 Jun; 23(6):503-10. PubMed ID: 24726001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-coding RNAs regulating mitochondrial function in cardiovascular diseases.
    Ao X; Ding W; Li X; Xu Q; Chen X; Zhou X; Wang J; Liu Y
    J Mol Med (Berl); 2023 May; 101(5):501-526. PubMed ID: 37014377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of miRNAs on the Pathophysiology of Cardiovascular Diseases.
    Silva DCPD; Carneiro FD; Almeida KC; Fernandes-Santos C
    Arq Bras Cardiol; 2018 Nov; 111(5):738-746. PubMed ID: 30484515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of non-coding circular RNAs and micro RNAs in the pathogenesis of cardiovascular diseases.
    Zhao G
    J Med Genet; 2018 Nov; 55(11):713-720. PubMed ID: 30177556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNAs as potential therapeutic targets and diagnostic biomarkers for cardiovascular disease with a particular focus on WO2010091204.
    Yang Y; Yu T; Jiang S; Zhang Y; Li M; Tang N; Ponnusamy M; Wang JX; Li PF
    Expert Opin Ther Pat; 2017 Sep; 27(9):1021-1029. PubMed ID: 28627982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in Using Circulating Micro-RNAs as Biomarkers for Cardiovascular Diseases.
    Felekkis K; Papaneophytou C
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crafting a Blueprint for MicroRNA in Cardiovascular Diseases (CVDs).
    Khan SU; Saeed S; Sheikh AN; Arbi FM; Shahzad A; Faryal U; Lu K
    Curr Probl Cardiol; 2023 Dec; 48(12):102010. PubMed ID: 37544621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in cardiovascular disease: an introduction for clinicians.
    Romaine SP; Tomaszewski M; Condorelli G; Samani NJ
    Heart; 2015 Jun; 101(12):921-8. PubMed ID: 25814653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review regulatory principles of non-coding RNAs in cardiovascular diseases.
    Li Y; Huo C; Pan T; Li L; Jin X; Lin X; Chen J; Zhang J; Guo Z; Xu J; Li X
    Brief Bioinform; 2019 Jan; 20(1):66-76. PubMed ID: 28968629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs: a novel class of potential therapeutic targets for cardiovascular diseases.
    Pan ZW; Lu YJ; Yang BF
    Acta Pharmacol Sin; 2010 Jan; 31(1):1-9. PubMed ID: 19966833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA Signature and Cardiovascular Dysfunction.
    Arunachalam G; Upadhyay R; Ding H; Triggle CR
    J Cardiovasc Pharmacol; 2015 May; 65(5):419-29. PubMed ID: 25384197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of microRNAs on cardiovascular diseases and aging.
    Sheikh MSA; Salma U
    J Int Med Res; 2024 Oct; 52(10):3000605241279190. PubMed ID: 39370977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs Determining Inflammation as Novel Biomarkers and Potential Therapeutic Targets.
    Kotsinas A; Sigala F; Garbis SD; Galyfos G; Filis K; Vougas K; Papalampros A; Johnson EE; Chronopoulos E; Georgakilas AG; Gorgoulis VG
    Curr Med Chem; 2015; 22(22):2666-79. PubMed ID: 26180004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.